Trial Details
AuthorisedBasic Information
| Clinical ID | c5083 |
|---|---|
| Identifier | EUCTR2017-003228-54-ES |
| Trial Title | A Phase IIa (proof of concept), randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory Bowel disease, mild to moderate Ulcerative Colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Code: PBF-677Pharmaceutical Form: Capsule, hardINN or Proposed INN: PBF-677Current Sponsor code: PBF-677Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Pharmaceutical form of th |
Participant Information
| Sponsor | PaloBiofarma S.L. |
|---|---|
| City | NULL |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |